Premium
Bioengineered hyaluronic acid elicited a nonantigenic T cell activation: Implications from cosmetic medicine and surgery to nanomedicine
Author(s) -
AlijotasReig Jaume,
Hindié Mathilde,
KandhayaPillai Renuka,
MiroMur Francesc
Publication year - 2010
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.32794
Subject(s) - hyaluronic acid , proinflammatory cytokine , immune system , peripheral blood mononuclear cell , materials science , nanomedicine , filler (materials) , medicine , adverse effect , inflammation , in vitro , immunology , pharmacology , chemistry , biochemistry , nanotechnology , nanoparticle , anatomy , composite material
Hyaluronan is known to act as a filling material of extracellular matrices and as an adhesive substrate for cellular migration. Consequently, it is widely used in aesthetic medicine and surgery, and it would be expected to be used in nanomedicine. Previous clinical case reports associated hyaluronic acid implants to delayed immune‐mediated adverse effects. A series of experiments to evaluate immune cell activation supported by this dermal filler and nanomedical biomaterial were performed. The study comprised a total of 12 individuals. Four healthy individuals, none with cosmetically injected dermal filler, were considered as control. Five individuals carried injections of hyaluronic acid dermal filler. Three individuals carried injections of hyaluronic acid dermal filler and presented delayed adverse effects related to the dermal filler. Hyaluronic acid–stimulated peripheral blood mononuclear cells (PBMC) produced low levels of pro‐inflammatory cytokines. Phytohemagglutinine (PHA)‐stimulated PBMC from patients with hyaluronic implants presenting adverse effects showed a slight increase in the production of interferon (IFN)‐γ and higher expression of CD25, CD69, or CD71. In conclusion, hyaluronic acid administration elicited a laboratory evidence of immune cell activation. Production of low levels of proinflammatory cytokines in vitro could be an observation for low‐grade inflammation in vivo resulting in T cell activation. © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010.